US Archives - Page 22 of 215 - European Medical Journal

Preschool child receiving respiratory treatment for acute wheezing symptoms

Azithromycin Shows No Benefit for Preschool Wheezing

Azithromycin did not improve acute preschool wheezing symptoms compared with placebo in an emergency department trial.

Extreme heat ICU capacity gaps across vulnerable U.S. states

Heat Vulnerability Outpaces ICU Capacity in U.S.

Extreme heat is exposing state-level ICU capacity gaps in regions already facing high climate-related health risk.

Dermatologist examining inflamed skin during chronic prurigo assessment.

Chronic Prurigo Care Needs Standardized Guidance

Chronic prurigo recommendations clarify diagnosis, severity assessment, and personalized treatment pathways for patients with persistent itch.

Patient holding foot in discomfort, representing gout flare resolution and recovery from joint pain

Patients Describe What Gout Flare Resolution Means

Gout flare resolution means more than pain relief, with patients describing recovery as a return to normal daily life.

Microscope used in respiratory infection research for Mycobacterium avium complex lung disease

ATS 2026: Phase IIIb Trial Advances MAC Lung Disease Care

A Phase IIIb trial is evaluating inhaled amikacin for newly diagnosed Mycobacterium avium complex lung disease.

Dermatologist discussing medical dermatology updates with a patient during a skin consultation.

SCALE 2026: Dermatology Pearls for Clinical Practice

SCALE 2026 highlighted medical dermatology updates spanning lasers, rosacea, acne, skin aging, and photoprotection.

Physician discussing endometriosis ovarian cancer risk with a patient during a gynecology consultation.

Endometriosis Ovarian Cancer Risk Needs Context

Endometriosis is linked to ovarian cancer risk, but absolute lifetime risk remains low for most patients.

Older adult receiving neurological care after traumatic brain injury and levetiracetam seizure prophylaxis.

Can Seizures Be Prevented After Brain Injury?

Levetiracetam appeared well tolerated after severe traumatic brain injury in octogenarians. Read more.

Pulmonologist reviewing lung imaging for idiopathic pulmonary fibrosis and inhaled treprostinil research.

ATS 2026: TETON-1 Inhaled Treprostinil Slows IPF Decline

Inhaled treprostinil slowed lung function decline in TETON-1, a Phase III trial in idiopathic pulmonary fibrosis.

Healthcare professional discussing GLP-1 weight loss and aesthetic treatment concerns with a patient.

SCALE 2026: GLP-1 Weight Loss Intensifies Aesthetic Care

GLP-1 weight loss may intensify aesthetic concerns linked to skin laxity, muscle tone, and body contouring.